百时美施贵宝 BMY 深 沪
等待开盘 03-27 09:30:00 美东时间
59.42
+0.460
+0.78%
华盛通- 最 高62.585
- 今 开58.845
- 成交量 428.85万股
- 最 低 56.45
- 昨 收 58.96
- 总市值 1.27亿
- 52周最高 62.8864
- 市盈率 静 19.07
- 换手率 201.43%
- 52周最低 42.52
- 委 比 -29.79%
- 总股本 0.02亿
- 历史最高 81.435
- 量 比 0
- 振 幅 10.41%
- 历史最低 7.98
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多FDA Approves Nivolumab With Chemotherapy For Previously Untreated Hodgkin Lymphoma
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-nivolumab-chemotherapy-previously-untreated-hodgkin-lymphoma
03-21 00:31
Bristol Myers Wins FDA Approval for Sotyktu for Psoriatic Arthritis
Bristol Myers won FDA approval for Sotyktu in active psoriatic arthritis, expanding its oral immunology franchise despite a slight after-hours stock dip.
03-08 04:30
当“小甜甜”成了“牛夫人”：上海医药见风转舵
一个多月前的2月4日，上海医药（601607.SH）公告称，拟通过产权交易所公开挂牌，转让所持中美上海施贵宝30%股权，挂牌底价不低于10.23亿元。 而早在...
03-06 19:10
不再只盯多巴胺：精神分裂症新药研发正在打开多条新通路
编者按：精神分裂症是一种严重的慢性精神疾病，影响全球上千万人口，并带来巨大的社会与经济负担。2024年，美国FDA批准百时美施贵宝（Bristol Myers...
03-05 07:39
免疫疗法的「下一场革命」
2025年，是In vivo CAR-T发展如火如荼的一年，阿斯利康、艾伯维、BMS等MNC企业纷纷在这一领域展开兼并收购。此外，多家In vivo CAR-...
02-24 11:50
Bristol-Myers Touts Promising Data From Blood Disorder Study
Bristol-Myers shares rise after Reblozyl study meets key goals in alpha-thalassemia patients, showing improved hemoglobin levels.
02-24 02:43
Bristol Myers Reports Phase 2 Results for Reblozyl in Alpha-Thalassemia Patients
Bristol Myers Squibb (NYSE:BMY) today announced positive top-line results from the ongoing, ex-US, Phase 2 registrational study (NCT05664737) evaluating Reblozyl® (luspatercept-aamt) versus placebo for anemia in
02-23 20:04
“轻装上阵”谋转型上海医药拟转让中美施贵宝股权
（来源：经济参考报） 上海医药（601607.SH）日前发布公告，公司拟通过产权交易所，以公开挂牌方式转让所持参股子公司中美上海施贵宝制药有限公司（简称“中美施...
02-11 04:10
上海医药加速创新年超20亿研发 拟售中美施贵宝股权变现超10亿
长江商报消息●长江商报记者沈右荣 追求资产价值最大化，上海医药（601607.SH）拟出售资产。 2月4日晚，上海医药公告，公司拟通过公...
02-06 07:58
公司简介
公司名称
|
百时美施贵宝
|
行业分类
|
制药
|
业务描述
|
百时美施贵宝是一家以“研发并提供创新药物，帮助患者战胜严重疾病”为使命的全球性生物制药公司。公司拥有约25000名员工。2016年，百时美施贵宝全球研发投入达近50亿美元，占全年产品净销售额的28%。
|
FDA Approves Nivolumab With Chemotherapy For Previously Untreated Hodgkin Lymphoma
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-nivolumab-chemotherapy-previously-untreated-hodgkin-lymphoma
03-21 00:31
Bristol Myers Wins FDA Approval for Sotyktu for Psoriatic Arthritis
Bristol Myers won FDA approval for Sotyktu in active psoriatic arthritis, expanding its oral immunology franchise despite a slight after-hours stock dip.
03-08 04:30
当“小甜甜”成了“牛夫人”：上海医药见风转舵
一个多月前的2月4日，上海医药（601607.SH）公告称，拟通过产权交易所公开挂牌，转让所持中美上海施贵宝30%股权，挂牌底价不低于10.23亿元。 而早在...
03-06 19:10
不再只盯多巴胺：精神分裂症新药研发正在打开多条新通路
编者按：精神分裂症是一种严重的慢性精神疾病，影响全球上千万人口，并带来巨大的社会与经济负担。2024年，美国FDA批准百时美施贵宝（Bristol Myers...
03-05 07:39
免疫疗法的「下一场革命」
2025年，是In vivo CAR-T发展如火如荼的一年，阿斯利康、艾伯维、BMS等MNC企业纷纷在这一领域展开兼并收购。此外，多家In vivo CAR-...
02-24 11:50
Bristol-Myers Touts Promising Data From Blood Disorder Study
Bristol-Myers shares rise after Reblozyl study meets key goals in alpha-thalassemia patients, showing improved hemoglobin levels.
02-24 02:43
Bristol Myers Reports Phase 2 Results for Reblozyl in Alpha-Thalassemia Patients
Bristol Myers Squibb (NYSE:BMY) today announced positive top-line results from the ongoing, ex-US, Phase 2 registrational study (NCT05664737) evaluating Reblozyl® (luspatercept-aamt) versus placebo for anemia in
02-23 20:04
“轻装上阵”谋转型上海医药拟转让中美施贵宝股权
（来源：经济参考报） 上海医药（601607.SH）日前发布公告，公司拟通过产权交易所，以公开挂牌方式转让所持参股子公司中美上海施贵宝制药有限公司（简称“中美施...
02-11 04:10
上海医药加速创新年超20亿研发 拟售中美施贵宝股权变现超10亿
长江商报消息●长江商报记者沈右荣 追求资产价值最大化，上海医药（601607.SH）拟出售资产。 2月4日晚，上海医药公告，公司拟通过公...
02-06 07:58
派息除权日
|
每股总股息
| 派息日期 |
2022-06-30
|
0.54
|
2022-08-01
|
2022-03-31
|
0.54
|
2022-05-02
|
2022-01-06
|
0.54
|
2022-02-01
|
2021-09-30
|
0.49
|
2021-11-01
|
2021-07-01
|
0.49
|
2021-08-02
|
2021-03-31
|
0.49
|
2021-05-03
|
2020-12-31
|
0.49
|
2021-02-01
|
2020-10-01
|
0.45
|
2020-11-02
|
2020-07-02
|
0.45
|
2020-08-03
|
2020-04-02
|
0.45
|
2020-05-01
|
2020-01-02
|
0.45
|
2020-02-03
|
2019-10-03
|
0.41
|
2019-11-01
|
2019-07-03
|
0.41
|
2019-08-01
|
2019-04-04
|
0.41
|
2019-05-01
|
2019-01-03
|
0.41
|
2019-02-01
|
2018-10-04
|
0.40
|
2018-11-01
|
2018-07-05
|
0.40
|
2018-08-01
|
2018-04-05
|
0.40
|
2018-05-01
|
2018-01-04
|
0.40
|
2018-02-01
|
2017-10-05
|
0.39
|
2017-11-01
|
2017-07-05
|
0.39
|
2017-08-01
|
2017-04-05
|
0.39
|
2017-05-01
|
2017-01-04
|
0.39
|
2017-02-01
|
2016-10-05
|
0.38
|
2016-11-01
|
2016-06-29
|
0.38
|
2016-08-01
|
2016-03-30
|
0.38
|
2016-05-02
|
2015-12-30
|
0.38
|
2016-02-01
|
2015-09-30
|
0.37
|
2015-11-02
|
2015-07-01
|
0.37
|
2015-08-03
|
2015-04-01
|
0.37
|
2015-05-01
|
2014-12-30
|
0.37
|
2015-02-02
|
2014-10-01
|
0.36
|
2014-11-03
|
2014-07-01
|
0.36
|
2014-08-01
|
2014-04-02
|
0.36
|
2014-05-01
|
2013-12-31
|
0.36
|
2014-02-03
|
2013-10-02
|
0.35
|
2013-11-01
|
2013-07-02
|
0.35
|
2013-08-01
|
2013-04-03
|
0.35
|
2013-05-01
|
2013-01-02
|
0.35
|
2013-02-01
|
2012-10-03
|
0.34
|
2012-11-01
|
2012-07-03
|
0.34
|
2012-08-01
|
2012-04-03
|
0.34
|
2012-05-01
|
2012-01-04
|
0.34
|
2012-02-01
|
2011-10-06
|
0.33
|
2011-11-01
|
2011-06-29
|
0.33
|
2011-08-01
|
2011-03-30
|
0.33
|
2011-05-02
|
2011-01-05
|
0.33
|
2011-02-01
|
2010-09-29
|
0.32
|
2010-11-01
|
2010-06-30
|
0.32
|
2010-08-02
|
2010-03-30
|
0.32
|
2010-05-03
|
2009-12-30
|
0.32
|
2010-02-01
|
2009-09-30
|
0.31
|
2009-11-02
|
2009-07-01
|
0.31
|
2009-08-03
|
2009-04-01
|
0.31
|
2009-05-01
|
2008-12-30
|
0.31
|
2009-02-02
|
2008-10-01
|
0.31
|
2008-11-03
|
2008-07-02
|
0.31
|
2008-08-01
|
2008-04-02
|
0.31
|
2008-05-01
|
2008-01-02
|
0.31
|
2008-02-01
|
2007-10-03
|
0.28
|
2007-11-01
|
2007-07-03
|
0.28
|
2007-08-01
|
2007-04-03
|
0.28
|
2007-05-01
|
2007-01-03
|
0.28
|
2007-02-01
|
2006-10-04
|
0.28
|
2006-11-01
|
2006-07-05
|
0.28
|
2006-08-01
|
2006-04-05
|
0.28
|
2006-05-01
|
2006-01-04
|
0.28
|
2006-02-01
|
2005-10-05
|
0.28
|
2005-11-01
|
2005-06-29
|
0.28
|
2005-08-01
|
2005-03-30
|
0.28
|
2005-05-02
|
2005-01-05
|
0.28
|
2005-02-01
|
2004-09-29
|
0.28
|
2004-11-01
|
2004-06-30
|
0.28
|
2004-08-02
|
2004-03-31
|
0.28
|
2004-05-03
|
2003-12-30
|
0.28
|
2004-02-02
|
2003-10-01
|
0.28
|
2003-11-03
|
2003-07-01
|
0.28
|
2003-08-01
|
2003-04-02
|
0.28
|
2003-05-01
|
2002-12-31
|
0.28
|
2003-02-01
|
2002-10-02
|
0.28
|
2002-11-01
|
2002-07-02
|
0.28
|
2002-08-01
|
2002-04-03
|
0.28
|
2002-05-01
|
2002-01-02
|
0.28
|
2002-02-01
|
2001-10-03
|
0.28
|
2001-11-01
|
2001-07-03
|
0.28
|
2001-08-01
|
2001-04-04
|
0.28
|
2001-05-01
|
2001-01-03
|
0.28
|
2001-02-01
|
2000-10-04
|
0.25
|
2000-11-01
|
2000-07-05
|
0.25
|
2000-08-01
|
2000-04-05
|
0.25
|
2000-05-01
|
2000-01-05
|
0.25
|
2000-02-01
|
1999-09-29
|
0.22
|
1999-11-01
|
1999-06-30
|
0.22
|
1999-08-01
|
1999-03-30
|
0.22
|
1999-05-01
|
1999-01-06
|
0.43
|
1999-02-01
|
1998-09-30
|
0.39
|
1998-11-01
|
1998-06-30
|
0.39
|
1998-08-01
|
1998-04-01
|
0.39
|
1998-05-01
|
1997-12-30
|
0.39
|
1998-02-01
|
1997-10-01
|
0.38
|
1997-11-01
|
1997-07-01
|
0.38
|
1997-08-01
|
1997-04-02
|
0.38
|
1997-05-01
|
1996-12-31
|
0.76
|
1997-02-01
|
1996-10-02
|
0.75
|
1996-11-01
|
1996-07-02
|
0.75
|
1996-08-01
|
1996-04-02
|
0.75
|
1996-05-01
|
1996-01-03
|
0.75
|
1996-02-01
|
1995-10-04
|
0.74
|
1995-11-01
|
1995-07-05
|
0.74
|
1995-08-01
|
1995-04-03
|
0.74
|
1995-05-01
|
1994-12-30
|
0.74
|
1995-02-01
|
1994-10-03
|
0.73
|
1994-11-01
|
1994-06-27
|
0.73
|
1994-08-01
|
1994-03-25
|
0.73
|
1994-05-01
|
1994-01-03
|
0.73
|
1994-02-01
|
1993-09-27
|
0.72
|
1993-11-01
|
1993-06-28
|
0.72
|
1993-08-01
|
1993-03-29
|
0.72
|
1993-05-01
|
1993-01-04
|
0.72
|
1993-02-01
|
1992-09-28
|
0.69
|
1992-11-01
|
1992-06-26
|
0.69
|
1992-08-01
|
1992-03-30
|
0.69
|
1992-05-01
|
1991-12-27
|
0.69
|
1992-02-01
|
1991-09-30
|
0.60
|
1991-11-01
|
1991-06-28
|
0.60
|
1991-08-01
|
1991-04-01
|
0.60
|
1991-05-01
|
1990-12-28
|
0.60
|
1991-02-01
|
1990-10-01
|
0.53
|
1990-11-01
|
1990-06-29
|
0.53
|
1990-08-01
|
1990-04-02
|
0.53
|
1990-05-01
|
1989-12-29
|
0.53
|
1990-02-01
|
1989-09-19
|
0.50
|
1989-11-01
|
1989-06-30
|
0.50
|
1989-08-01
|
1989-04-03
|
0.50
|
1989-05-01
|
1988-12-30
|
0.50
|
1989-02-01
|
1988-10-03
|
0.42
|
1988-11-01
|
1988-06-27
|
0.42
|
1988-08-01
|
1988-03-25
|
0.42
|
1988-05-01
|
1988-01-04
|
0.42
|
1988-02-01
|
1987-09-28
|
0.35
|
1987-11-01
|
1987-06-26
|
0.35
|
1987-08-01
|
1987-03-30
|
0.70
|
1987-05-01
|
1986-12-26
|
0.70
|
1987-02-01
|
1986-09-29
|
0.55
|
1986-11-01
|
1986-06-27
|
0.55
|
1986-08-01
|
1986-03-31
|
0.55
|
1986-05-01
|
1985-12-07
|
0.47
|
1986-02-01
|
1985-09-30
|
0.47
|
1985-11-01
|
1985-06-08
|
0.47
|
1985-08-01
|
1985-03-09
|
0.47
|
1985-05-01
|
1984-12-08
|
0.40
|
1985-02-01
|
1984-10-01
|
0.40
|
1984-11-01
|
1984-06-29
|
0.40
|
1984-08-01
|
1984-04-02
|
0.40
|
1984-05-01
|
1983-12-30
|
0.30
|
1984-02-01
|
1983-10-03
|
0.30
|
1983-11-01
|
1983-07-01
|
0.30
|
1983-08-01
|
1983-01-03
|
0.52
|
1983-02-01
|
1982-10-04
|
0.52
|
1982-11-01
|
1982-07-02
|
0.52
|
1982-08-01
|
1982-04-04
|
0.60
|
1982-05-01
|
1982-04-02
|
0.52
|
1982-05-01
|
1982-01-04
|
0.46
|
1982-02-01
|
1981-10-05
|
0.46
|
1981-11-01
|
1981-07-06
|
0.46
|
1981-08-01
|
1981-04-06
|
0.46
|
1981-05-01
|
1981-01-05
|
0.40
|
1981-02-01
|
1980-10-06
|
0.40
|
1980-11-01
|
1980-06-30
|
0.40
|
1980-08-01
|
1980-03-28
|
0.40
|
1980-05-01
|
1979-12-28
|
0.36
|
1980-02-01
|
1979-10-05
|
0.36
|
1979-11-01
|
1979-06-29
|
0.36
|
1979-08-01
|
1979-04-02
|
0.36
|
1979-05-01
|
1978-12-29
|
0.31
|
1979-02-01
|
1978-10-02
|
0.31
|
1978-11-01
|
1978-06-30
|
0.31
|
1978-08-01
|
1978-03-31
|
0.31
|
1978-05-01
|
1977-12-30
|
0.28
|
1978-02-01
|
1977-10-03
|
0.28
|
1977-11-01
|
1977-06-27
|
0.28
|
1977-08-01
|
